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A comparison of human dopamine fl-hydroxylase (EC 1.14.17.1) with bovine peptide C-terminal ~t-amidating enzyme 
(EC 1.14.17.3), revealed a 28% identity extending throughout a common catalytic domain of approximately 270 residues. 
The shared biochemical properties of these two enzymes from neurosecretory granules uggests that the sequence similari- 
ty reflects a genuine homology and provides a structural basis for a new family of copper type II, ascorbate-dependent 
monooxygenases. 
Dopamine fl-hydroxylase; Peptide ~t-amidating enzyme; Sequence similarity; Copper type II monooxygenase 
1. INTRODUCTION 
Dopamine ~'-hydroxylase (DBH; EC 1.14.17.1) 
catalyses the conversion of dopamine to the neuro- 
transmitter norepinephrine (for review see [1]). The 
possible role of DBH as a control point in 
catecholamine biosynthesis, mechanistic questions 
regarding the involvement of copper in the hydrox- 
ylation reaction, and interactions with other pro- 
teins and cofactors within the adrenal chromaffin 
granule, have generated intense research towards 
understanding the structure and function of this 
protein. The recent availability of cDNA-derived 
protein sequences [2,3] and a complete gene se- 
quence for human DBH [3] are important advances 
but have not provided irect answers to these ques- 
tions. 
In the course of our active-site mapping studies 
of bovine DBH we have located attachment sites 
for two mechanism-based inhibitors [4,5] and have 
determined approximately 85°70 of the primary 
structure (unpublished results). The attachment 
site for ~-ethinyltyramine at His 398 was isolated 
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as a 25 residue tryptic peptide that included a 
putative copper binding site [5]. A search of the 
protein sequence data banks with this peptide 
revealed, in addition to a match with the cor- 
responding section from human DBH, a similarity 
with peptide C-terminal ce-amidating enzyme 
(PAM; EC 1.14.17.3) from Xenopus laevis [6]. 
Because both enzymes are classified as copper type 
II, ascorbate-dependent monooxygenases, we 
decided to investigate possible similarities in 
primary structure between these two proteins using 
sequence comparison methods on the DBH and 
PAM sequences available in the databases. 
2. EXPERIMENTAL 
Computer analyses were performed on a VAX/VMS system 
using the suite of programs purchased from the University of 
Wisconsin Genetics Computer Group (UWGCG) [7]. Initial 
searches were done using the FASTA program with the current 
Dayhoff library of 20,535 protein sequence ntries. Human 
DBH, frog PAM and other copper binding proteins were found 
in the current SwissProt protein database (release 10.0 3/89). 
Other protein sequences including bovine PAM were obtained 
by using TRANSLATE on the appropriate cDNA sequences 
retrieved from the GenBank database. Dotplot comparisons 
were done with the COMPARE program and alignments pro- 
duced with the GAP program. 
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3. RESULTS 
Our initial search of the protein databases with 
the tryptic peptide containing the attachment site 
of B-ethinyltyramine gave a score of 96°7o identity 
over 25 amino acids with human DBH and 47°7o 
over 17 amino acids with the peptide ce-amidating 
enzyme from the frog Xenopus laevis [6]. When the 
FASTA search was repeated using the entire 
human DBH sequence the only match with a 
significant score over an extended length of poly- 
peptide chain was with frog PAM. 
After our initial finding of similarity between 
human DBH and frog PAM we carried out further 
intra-vertebrate s quence comparisons between 
human DBH and bovine PAM. The full-length 
bovine PAM cDNA encodes a 976 residue protein 
[8]. This contains a 25 residue signal sequence 
followed by a putative 10 residue propeptide, an 
831 residue catalytic/intragranular domain, and a 
25 residue transmembrane domain with an 86 
residue cytoplasmic tail. A dotplot comparison of 
PAM and DBH showed a clear diagonal section 
characteristic of sequence similarity over a section 
approximately 280 residues long corresponding to
the centre of DBH and the N-terminal region of 
PAM (fig.l). The relationship between the two 
proteins is more clearly shown in the expanded plot 
of the diagonal section in fig.2. 
An alignment of the two sequences obtained 
with the GAP program is shown in fig.3. The small 
deviations of the matching sections from the true 
diagonal in fig.2 indicate that a good alignment 
could be achieved using a gap weight favouring 
small insertions and deletions over large ones. Bas- 
ed on the slightly larger DBH section of 295 
residues aligned with 270 residues from PAM, the 
number of identical positions was 27°7o. The 
similarity score calculated by GAP from probabili- 
ty of amino acid replacements during evolution 
was 52% indicating structural conservation by the 
exchange of similar residues in positions of non- 
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Fig. 1. A dotplot comparison using the program COMPARE, of bovine PAM against human DBH. A window size of 15 and stringency 
of 10.0 were used to filter the plot to 253 points. 
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Fig.2. An expanded otplot of the similarity diagonal from fig.1. A window size of 15 and stringency of 9.0 filtered the plot to 113 
points. 
identity. However, it should be noted that com- 
parison algorithms of this type can produce a 
number of alternative alignments with similar 
scores. 
4. DISCUSSION 
The finding of sequence similarity throughout an 
extended section of primary structure, with only 
limited gapping, suggests a genuine homology in 
the sense that the two proteins may have evolved 
from a common precursor. The possible biological 
significance is supported by previous proposals of 
similarity between these two enzymes based on bio- 
chemical evidence alone [1,9]. PAM enzymes 
catalyse the conversion of carboxy-terminal glycine 
extended peptides to an ~-amidated product. This 
occurs concomitantly with secretion and is essential 
for full biological potency of some pro-hormones 
(for reviews ee [9,10]). Biochemical similarities be- 
tween DBH and PAM include the following. Both 
enzymes are type II copper-containing monoox- 
ygenases from secretory granules, requiring ascor- 
bate and molecular oxygen. The ascorbate is re- 
cycled in both cases via a mitochondrial semide- 
hydroascorbate r ductase and cytochrome b561 
[11,12]. They have similar kinetic mechanisms, 
both enzymes can use catechol or ferrocyanide as 
single-electron reductants. They also both show 
significant deuterium isotope effects in Vmax, al- 
though the value for PAM is significantly larger 
[13]. 
Several lines of evidence indicate that the section 
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DBH 190 EPELPSDACTMEVQAPNIQIPSQETTYWCYIKELPKGFSRHHI IKYEP IV  239  
I I I I  I I I  II I I 
PAM 50 . IP IDSSDFALDIRMPGV.TPKQSDTYFCMSVRLPMD.EEAFVIDFKP. .  94 
240  TKGNEALVHHMEVFQCAPEMDSVPHFSGPCDSKMKPDRLNYCRHVLAAWA 289 
IIII I I I II II I I III 
95 .RASMDTVHHMLLFGCNMPASTGNYWF. .CDEGTCTDKAN . . . .  I LYAWA 137 
------  * * 
290 LGAKAFYYPEEAGLAFGGPGSSRYLRLEVHYHNPLVI  . EGRNDS SGIRLY  338 
I I I II I I I III I II I 
138 RNAPPTRLPKGVGFRVGGETGSKYFVLQVHYGD I SAFRDNHKDCSGVSLH 187 
339 
188 
YTAKLRRFNAGIMELGLVYTPVMAIPPRETAF ILTGYCTDKCTQLALPP  S 388  
I II I I III 
LTRLPQPL IAGMYLMMSVDT . . . V IPP  . . GGKVVNSDI  SCHYKKYPM.  . . 229  
389 
230 
G IH IFASQLHTHLTGRKVVTVLVRDGREWE IVNQDNHYSPHF . QE IRMLK 437 
I II III I I II I I II I 
• . HVFAYRVHTHHLGKVVSGYRVRNG . QWTL IGRQ . . . SPQLPQAFYPVE 273 
438 KVVSVHPGDVL ITSCTYNTEDR.  ELATVGGFGILEEMCVNYVHYYPQTQ 485 
I I II I I I I I II III I II 
274 HPVDVSFGDI I J kARCVFTGEGRTEVTHIGGTSS.DEMCNLY IMYYMEA.  320  
Fig.3. An optimised alignment of the similarity region between human DBH (top) and bovine PAM using the GAP program with a 
gap setting of 2 and length weight of 0.3. The positions of gaps are marked with dots. Identical residues are indicated with vertical lines. 
Two histidine clusters are underlined and the position of conserved Cys residues i  marked with an asterisk. 
of similarity between these two enzymes represents 
a common catalytic domain. Between rat, bovine 
and frog PAMs this section is highly conserved and 
tissue-specific truncated forms of active PAM of 
between 300 and 350 residues can be produced in 
vivo by alternative mRNA splicing and/or endo- 
proteolytic processing [8]. Residues 38 to 381 of 
frog PAM expressed in E. coli show amidating ac- 
tivity in vitro [6]. Independent evidence for an ex- 
tended catalytic domain in DBH comes from at- 
tachment sites of mechanism-based inhibitors. 
Three of these have recently been identified, 
Tyr 216 [4] and Tyr 357 for p-cresol (unpublished 
results) and His 398 for fl-ethinyltyramine [5]. The 
chemistry of inactivation for these compounds in- 
dicates that covalent incorporation should be 
restricted to the vicinity of the active site. This idea 
is supported by the location of all 3 modified 
residues within the putative catalytic domain 
described above. Characterisation of the attach- 
ment site peptides [4,5] together with extensive par- 
tial sequence data (unpublished observations) in- 
dicate approximately 95°7o sequence identity be- 
tween human and bovine DBH throughout this do- 
main. 
Several consensus features in this section of the 
PAM sequences from 3 species are also present in 
DBH (fig.3). Out of 7 Cys residues in PAM, 5 are, 
allowing for small gaps, in identical or similar posi- 
tions in DBH. This implies some conservation of 
the pattern of intra-chain disulphide formation. 
Two histidine clusters are also conserved at posi- 
tions 250 and 398 in human DBH. Recent spectro- 
scopic studies have been carried out to examine the 
local environment of the copper sites in bovine 
DBH [14-18]. There is a general agreement of a 
coordination sphere of 3-4 histidyl imidazoles for 
each Cu 2÷ although none of the studies suggest if 
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additional igands are necessary in changing from 
an occupancy of 1 to 2 copper atoms per subunit. 
Direct evidence for a ligand motif of the type H-X- 
H in copper type II proteins comes from the 
3-dimensional structure of the copper binding site 
in superoxide dismutase [19]. Two candidates for 
ligand clusters of this type, conserved between 3 
PAM species and human DBH, would be -H-X-M- 
and H-X-H- as indicated in fig.3. The proximity of 
Met as a ligand is supported by the data of Scott et 
al. [14] suggesting Cu-S coordination to the reduc- 
ed, Cu ÷ form of DBH. It has recently been propos- 
ed that the catalytically competent form of DBH 
contains two reduced coppers per subunit in func- 
tionally non-equivalent sites separated by more 
than 4 ,~ [18]. This clearly requires more ligands 
than the two pairs indicated above. Although the 
copper binding stoichiometry of PAM has not yet 
been established, both enzymes contain additional 
potential igand clusters but in different positions. 
These would include HYH at position 319-321 in 
DBH and an unusual Met/His cluster conserved at 
position 345 in PAM. 
To extend our search for possible copper binding 
domains we compared DBH to some of the other 
major types of copper proteins for which sequences 
were available in the databases, including other 
copper type II enzymes and those containing type I 
and type III copper sites amongst which evolu- 
tionary relationships have already been detected 
[20,21]. Some of these were only available from 
GenBank entries and would therefore not have 
been accessible to our initial search of the Dayhoff 
library. Dotplots of human DBH against human 
tyrosinase, tyrosine-3-hydroxylase, ceroplasmin, 
cytochrome oxidase, superoxide dismutase, Neuro- 
spora laccase, and lobster haemocyanin, were 
made at a similar level of signal filtration to that 
used in fig. 1 but no extended iagonals were seen. 
Although these results do not preclude the ex- 
istence of distant relationships between DBH and 
these proteins they support our proposal that on 
the basis of both primary structure similarities and 
biochemical evidence DBH and PAM are members 
of a new protein family of type II copper monoox- 
ygenases. 
REFERENCES 
[1] Stewart, L.C. and Klinman, J.P. (1988) Annu. Rev. Bio- 
chem., 551-592. 
[2] Lamouroux, A., Vigny, A., Faucon Biguet, N., Darmon, 
M.C., Franck, R., Henry, J.-P. and Mallet, J. (1987) 
EMBO J. 6, 3931-3937. 
[3] Kobayashi, K., Kurosawa, Y., Fujita, K. and Nagatsu, T. 
(1989) Nucleic Acids Res. 17, 1089-1102. 
[4] DeWolf, W.E., jr, Carr, S.A., Varrichio, A., Goodhart, 
P.J., Mentzer, M.A., Roberts, G.D., Southan, C., Dolle, 
R.E. and Kruse, L.I. (1988) Biochemistry 27, 9093-9101. 
[5] DeWolf, W.E., jr, Chambers, P.A., Southan, C., 
Goodhart, P.J., Saunders, D. and Kruse, L.I. (1989) Bio- 
chemistry 28, 3833-3842. 
[6] Ohsuye, K., Kitano, K., Wada, Y., Fuchimura, K., 
Tanaka, S., Mizuno, K. and Matsuo, H. (1988) Biochem. 
Biophys. Res. Commun. 150, 1275-1281. 
[7] Devereux, J., Haeberli, P. and Smithies, O. (1984) Nucleic 
Acids Res. 12, 387-395. 
[8] Stoffers, D.A., Green, C.B.-R. and Eipper, B.A. (1989) 
Proc. Natl. Acad. Sci. USA 86, 735-739. 
[9] Eipper, B.H. and Mains, R.E. (1988) Annu. Rev. Physiol. 
50, 333-344. 
[10] Bradbury, A.F. and Smyth, D.G. (1987) Biosci. Rep. 7, 
907 -916. 
Ill] Diliberto, E.J., jr, Menneti, F.S., Knoth, J., Daniels, 
A.J., Kizer, J.S. and Viveros, O.H. (1987) Ann. NY Acad. 
Sci. 498, 28-53. 
[12] Perin, M.S., Fried, V.A., Slaughter, C.A. and Siidhof, 
T.C. (1988) EMBO J. 7, 2697-2703. 
[13] Kizer, J.S., Bateman, R.C., jr, Miller, C.R., Humm, J., 
Busby, W.H., jr and Youngblood, W.W. (1986) Endo- 
crinology 118, 2262-2267. 
[14] Scott, R.A., Sullivan, R.J., DeWolf, W.E., jr, Dolle, R.E. 
and Kruse, L.I. 0988) Biochemistry 27, 5411-5417. 
[15] Blackburn~ N.J., Concannon, M., Shahiyan, S.K., 
Mabbs, F.E. and Collison, D. (1988) Biochemistry 27, 
6001-6008. 
[16] McCracken, J., Desai, P.R., Papadopoulos, N.J., 
Villafranca, J.J. and Peisach, J. (1988) Biochemistry 27, 
4133-4137. 
[17] Blumberg, W.E., Desai, P.R., Powers, L., Freedman, 
J.H. and Villafranca, J.J. (1989) J. Biol. Chem. 264, 
6029-6032. 
[18] Brenner, M.C. and Klinman, J.P. (1989) Biochemistry 28, 
4664-4670. 
[19] Tainer, J.A., Getzoff, E.D., Beem, K.M., Richardson, 
J.S. and Richardson, D.C. (1982) J. Mol. Biol. 160, 
181-217. 
[20] Lerch, K. and Germann, U.A. (1988) in: Oxidases and 
Related Redox Systems (King, T.E., Mason, S.H. and 
Morrison, M. eds) pp. 331-348, Alan R. Liss, New York. 
[21] Ryd6n, L. (1988) in: Oxidases and Related Redox Systems 
(King, T.E., Mason, S.H. and Morrison, M. eds) pp. 
349-366, Alan R. Liss, New York. 
120 
